Arijit Biswas Selected Research

Conditioned Culture Media

1/2020	Hypoxic Wharton's Jelly Stem Cell Conditioned Medium Induces Immunogenic Cell Death in Lymphoma Cells.
1/2020	Inhibition of growth of Asian keloid cells with human umbilical cord Wharton's jelly stem cell-conditioned medium.
1/2019	Histological, immunohistochemical, and genomic evaluation of excisional and diabetic wounds treated with human Wharton's jelly stem cells with and without a nanocarrier.
12/2017	Induction of Immunogenic Cell Death in Lymphoma Cells by Wharton's Jelly Mesenchymal Stem Cell Conditioned Medium.
1/2016	Human Umbilical Cord Wharton's Jelly Stem Cell Conditioned Medium Induces Tumoricidal Effects on Lymphoma Cells Through Hydrogen Peroxide Mediation.
8/2014	Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells.
4/2014	A nanoscaffold impregnated with human wharton's jelly stem cells or its secretions improves healing of wounds.
2/2014	Human Wharton's jelly stem cells and its conditioned medium enhance healing of excisional and diabetic wounds.
2/2013	Human Wharton's jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice.
6/2012	Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arijit Biswas Research Topics

Disease

14	Hemorrhage 01/2022 - 03/2006
12	Neoplasms (Cancer) 08/2021 - 01/2007
7	Thrombosis (Thrombus) 03/2022 - 02/2005
7	Venous Thrombosis (Deep-Vein Thrombosis) 03/2022 - 02/2005
7	Stroke (Strokes) 11/2017 - 11/2008
5	COVID-19 05/2021 - 01/2020
4	Lymphoma (Lymphomas) 01/2020 - 08/2014
4	Wounds and Injuries (Trauma) 01/2019 - 02/2014
4	Ischemic Stroke 01/2019 - 03/2009
3	von Willebrand Diseases (von Willebrand's Disease) 01/2021 - 10/2012
3	Pre-Eclampsia (Preeclampsia) 01/2019 - 01/2014
3	Aneuploidy (Aneuploid) 01/2017 - 04/2012
2	Hyperhomocysteinemia 03/2022 - 03/2006
2	1 Combined Deficiency Of Vitamin K-Dependent Clotting Factors 01/2022 - 01/2021
2	Gestational Diabetes (Gestational Diabetes Mellitus) 08/2021 - 01/2015
2	Pregnancy Complications 08/2021 - 11/2018
2	Infections 03/2021 - 04/2017
2	Keloid 01/2020 - 05/2014
2	Fetofetal Transfusion (Twin Transfusion Syndrome) 01/2018 - 06/2017
2	Vascular Diseases (Vascular Disease) 11/2017 - 09/2014
2	Hydatidiform Mole (Molar Pregnancy) 01/2015 - 10/2014
2	Carcinogenesis 01/2015 - 02/2012
2	Carcinoma (Carcinomatosis) 02/2013 - 06/2012
2	Osteosarcoma (Osteogenic Sarcoma) 02/2013 - 06/2012
2	Activated Protein C Resistance (APC Resistance) 09/2009 - 06/2008
2	Hemophilia A (Haemophilia) 03/2008 - 03/2006
1	Birth Weight (Birth Weights) 08/2021
1	Hemolysis 01/2021
1	Cross Infection (Nosocomial Infection) 01/2020
1	Cicatrix (Scar) 11/2019
1	Rupture 11/2019
1	Type 3 von Willebrand Disease 11/2019
1	Uveal melanoma 10/2019

Drug/Important Bio-Agent (IBA)

11	Conditioned Culture MediaIBA 01/2020 - 06/2012
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2008
5	von Willebrand FactorIBA 01/2021 - 10/2012
5	factor V LeidenIBA 02/2017 - 02/2005
4	Protein CIBA 01/2021 - 02/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022 - 05/2010
3	HomocysteineIBA 03/2022 - 03/2006
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022 - 08/2014
3	Vitamin K FDA Link 01/2022 - 08/2014
3	Factor XIII (Coagulation Factor XIII)IBA 05/2019 - 06/2010
3	AntigensIBA 09/2014 - 11/2008
3	Bromodeoxyuridine (BrdU)IBA 08/2014 - 06/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 06/2012
3	Green Fluorescent ProteinsIBA 04/2014 - 12/2009
3	Factor VIII (Coagulation Factor VIII)IBA 09/2009 - 03/2006
2	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 02/2007
2	CytokinesIBA 05/2021 - 05/2014
2	AnticoagulantsIBA 03/2021 - 01/2018
2	Prothrombin (Factor II)IBA 01/2021 - 09/2009
2	Hemostatics (Antihemorrhagics)IBA 01/2021 - 05/2009
2	AntithrombinsIBA 10/2020 - 01/2008
2	VaccinesIBA 01/2020 - 04/2017
2	MicroRNAs (MicroRNA)IBA 10/2019 - 12/2017
2	CollagenIBA 01/2019 - 04/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2018
2	Plasminogen Activators (Plasminogen Activator)IBA 11/2017 - 04/2010
2	Plasminogen Activator Inhibitor 1IBA 11/2017 - 04/2010
2	Cell-Free Nucleic AcidsIBA 06/2017 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2013
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016 - 08/2014
2	Glutathione PeroxidaseIBA 09/2014 - 08/2014
2	Superoxide DismutaseIBA 08/2014 - 04/2014
2	Filaggrin ProteinsIBA 04/2014 - 02/2014
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2014 - 02/2014
2	Tissue Inhibitor of Metalloproteinase-1IBA 04/2014 - 02/2014
2	Keratins (Keratin)IBA 04/2014 - 02/2014
2	involucrinIBA 04/2014 - 02/2014
2	polyacrylamideIBA 03/2013 - 05/2009
2	Antiphospholipid AntibodiesIBA 09/2009 - 04/2005
2	Factor V (Coagulation Factor V)IBA 09/2009 - 06/2008
2	EnzymesIBA 03/2009 - 01/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2022
1	Matrix Gla ProteinIBA 01/2022
1	PPAR gammaIBA 08/2021
1	MethyltransferasesIBA 08/2021
1	Glucose (Dextrose)FDA LinkGeneric 08/2021
1	Heme (Haem)IBA 01/2021
1	glutamyl carboxylase (gamma-glutamyl carboxylase)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 12/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	CalreticulinIBA 01/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 11/2019
1	Deubiquitinating EnzymesIBA 10/2019
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 10/2019
1	DisulfidesIBA 04/2019

Therapy/Procedure

8	Therapeutics 03/2021 - 04/2005
3	Cesarean Section (Caesarean Section) 08/2021 - 01/2008
3	Transplantation 11/2015 - 02/2012
2	Injections 01/2019 - 02/2013
2	Lasers (Laser) 06/2017 - 03/2013
2	Fetal Therapies (Fetal Therapy) 06/2017 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 03/2021
1	Personal Protective Equipment 01/2020
1	Anesthesia 01/2020